Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Treatment of type 2 diabetes by free Fatty Acid receptor agonists
Kenneth R Watterson, Brian D Hudson,
Trond Ulven
, Graeme Milligan
58
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Treatment of type 2 diabetes by free Fatty Acid receptor agonists'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Free Fatty Acid Receptors
100%
Type 2 Diabetes Prevention
100%
Metabolic
50%
Potential Treatments
50%
Free Fatty Acids
50%
Agonism
50%
FFA1
50%
Hypoglycemia Risk
25%
Liver Toxicity
25%
Clinical Targets
25%
FFA3
25%
Type 2 Diabetes Mellitus (T2DM)
25%
Type 2 Diabetic Patients
25%
Synthetic Ligands
25%
FFA2
25%
As(III)
25%
Risk Reduction
25%
FFA4
25%
Glycemic Control
25%
Ligand-specific
25%
Clinical Trials
25%
Insulin Sensitivity
25%
G Protein-coupled Receptor
25%
Weight Loss
25%
Drug Development Program
25%
HbA1c Levels
25%
Anti-inflammatory Effect
25%
3 Fatty Acids
25%
Short-chain Fatty Acids
25%
Specific Features
25%
Inflammatory Process
25%
Inflammation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor Agonist
100%
Fatty Acid
100%
Non Insulin Dependent Diabetes Mellitus
100%
Receptor
42%
Inflammation
28%
Clinical Study
14%
Antiinflammatory Activity
14%
Hypoglycemia
14%
Hemoglobin A1c
14%
Preclinical Study
14%
Drug Development
14%
Short Chain Fatty Acid
14%
Hepatotoxicity
14%
Anti-Inflammatory Drug
14%
G Protein Coupled Receptor
14%
Clinical Trial
14%
Biochemistry, Genetics and Molecular Biology
Free Fatty Acids
100%
Receptor Agonists
100%
Clinical Study
16%
Antiinflammatory Activity
16%
Short-Chain Fatty Acid
16%
Agonist
16%
Insulin Sensitivity
16%
Preclinical Study
16%
G Protein Coupled Receptor
16%
Glycemic Control
16%
Clinical Trial
16%